Current challenges and opportunities for research on borderline ovarian tumors

Mark E. Sherman, Jules Berman, Michael J. Birrer, Kathleen R. Cho, Lora Hedrick Ellenson, Fred Gorstein, Jeffrey D. Seidman

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

This article summarizes key issues for future research on borderline ovarian tumors that emerged at a National Cancer Institute-sponsored Borderline Ovarian Tumor Workshop held in August 2003 in Bethesda, MD. Limitations in existing research and opportunities for future advances have been highlighted. The application of new molecular techniques in combination with improved study designs holds promise for elucidating the pathogenesis of these tumors and revealing the source of the extra-ovarian lesions ("implants") with which they are frequently associated. Clarification of the etiology of borderline tumors and the pathogenesis of their associated implants is critical for improving pathological diagnosis, revising the classification system of ovarian neoplasms, and developing optimal, evidence-based clinical management algorithms.

Original languageEnglish (US)
Pages (from-to)961-970
Number of pages10
JournalHuman Pathology
Volume35
Issue number8
DOIs
StatePublished - Aug 2004

Fingerprint

Research
Neoplasms
National Cancer Institute (U.S.)
Ovarian Neoplasms
Education

Keywords

  • borderline
  • borderline ovarian tumor
  • BOT
  • epidemiology
  • low malignant potential
  • M-BOT
  • mucinous borderline ovarian tumor
  • neoplasm
  • ovary
  • pathology
  • S-BOT
  • SEER
  • serous borderline ovarian tumor
  • Surveillance, Epidemiology and End Results

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Sherman, M. E., Berman, J., Birrer, M. J., Cho, K. R., Ellenson, L. H., Gorstein, F., & Seidman, J. D. (2004). Current challenges and opportunities for research on borderline ovarian tumors. Human Pathology, 35(8), 961-970. https://doi.org/10.1016/j.humpath.2004.03.007

Current challenges and opportunities for research on borderline ovarian tumors. / Sherman, Mark E.; Berman, Jules; Birrer, Michael J.; Cho, Kathleen R.; Ellenson, Lora Hedrick; Gorstein, Fred; Seidman, Jeffrey D.

In: Human Pathology, Vol. 35, No. 8, 08.2004, p. 961-970.

Research output: Contribution to journalArticle

Sherman, ME, Berman, J, Birrer, MJ, Cho, KR, Ellenson, LH, Gorstein, F & Seidman, JD 2004, 'Current challenges and opportunities for research on borderline ovarian tumors', Human Pathology, vol. 35, no. 8, pp. 961-970. https://doi.org/10.1016/j.humpath.2004.03.007
Sherman, Mark E. ; Berman, Jules ; Birrer, Michael J. ; Cho, Kathleen R. ; Ellenson, Lora Hedrick ; Gorstein, Fred ; Seidman, Jeffrey D. / Current challenges and opportunities for research on borderline ovarian tumors. In: Human Pathology. 2004 ; Vol. 35, No. 8. pp. 961-970.
@article{e2bfcd52fef747fa98d254d23ca65846,
title = "Current challenges and opportunities for research on borderline ovarian tumors",
abstract = "This article summarizes key issues for future research on borderline ovarian tumors that emerged at a National Cancer Institute-sponsored Borderline Ovarian Tumor Workshop held in August 2003 in Bethesda, MD. Limitations in existing research and opportunities for future advances have been highlighted. The application of new molecular techniques in combination with improved study designs holds promise for elucidating the pathogenesis of these tumors and revealing the source of the extra-ovarian lesions ({"}implants{"}) with which they are frequently associated. Clarification of the etiology of borderline tumors and the pathogenesis of their associated implants is critical for improving pathological diagnosis, revising the classification system of ovarian neoplasms, and developing optimal, evidence-based clinical management algorithms.",
keywords = "borderline, borderline ovarian tumor, BOT, epidemiology, low malignant potential, M-BOT, mucinous borderline ovarian tumor, neoplasm, ovary, pathology, S-BOT, SEER, serous borderline ovarian tumor, Surveillance, Epidemiology and End Results",
author = "Sherman, {Mark E.} and Jules Berman and Birrer, {Michael J.} and Cho, {Kathleen R.} and Ellenson, {Lora Hedrick} and Fred Gorstein and Seidman, {Jeffrey D.}",
year = "2004",
month = "8",
doi = "10.1016/j.humpath.2004.03.007",
language = "English (US)",
volume = "35",
pages = "961--970",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "8",

}

TY - JOUR

T1 - Current challenges and opportunities for research on borderline ovarian tumors

AU - Sherman, Mark E.

AU - Berman, Jules

AU - Birrer, Michael J.

AU - Cho, Kathleen R.

AU - Ellenson, Lora Hedrick

AU - Gorstein, Fred

AU - Seidman, Jeffrey D.

PY - 2004/8

Y1 - 2004/8

N2 - This article summarizes key issues for future research on borderline ovarian tumors that emerged at a National Cancer Institute-sponsored Borderline Ovarian Tumor Workshop held in August 2003 in Bethesda, MD. Limitations in existing research and opportunities for future advances have been highlighted. The application of new molecular techniques in combination with improved study designs holds promise for elucidating the pathogenesis of these tumors and revealing the source of the extra-ovarian lesions ("implants") with which they are frequently associated. Clarification of the etiology of borderline tumors and the pathogenesis of their associated implants is critical for improving pathological diagnosis, revising the classification system of ovarian neoplasms, and developing optimal, evidence-based clinical management algorithms.

AB - This article summarizes key issues for future research on borderline ovarian tumors that emerged at a National Cancer Institute-sponsored Borderline Ovarian Tumor Workshop held in August 2003 in Bethesda, MD. Limitations in existing research and opportunities for future advances have been highlighted. The application of new molecular techniques in combination with improved study designs holds promise for elucidating the pathogenesis of these tumors and revealing the source of the extra-ovarian lesions ("implants") with which they are frequently associated. Clarification of the etiology of borderline tumors and the pathogenesis of their associated implants is critical for improving pathological diagnosis, revising the classification system of ovarian neoplasms, and developing optimal, evidence-based clinical management algorithms.

KW - borderline

KW - borderline ovarian tumor

KW - BOT

KW - epidemiology

KW - low malignant potential

KW - M-BOT

KW - mucinous borderline ovarian tumor

KW - neoplasm

KW - ovary

KW - pathology

KW - S-BOT

KW - SEER

KW - serous borderline ovarian tumor

KW - Surveillance, Epidemiology and End Results

UR - http://www.scopus.com/inward/record.url?scp=3843143996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3843143996&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2004.03.007

DO - 10.1016/j.humpath.2004.03.007

M3 - Article

C2 - 15297963

AN - SCOPUS:3843143996

VL - 35

SP - 961

EP - 970

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 8

ER -